Intellus Advisors LLC Merck & Co., Inc. Transaction History
Intellus Advisors LLC
- $671 Billion
- Q2 2025
A detailed history of Intellus Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Intellus Advisors LLC holds 3,781 shares of MRK stock, worth $325,128. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,781
Previous 3,589
5.35%
Holding current value
$325,128
Previous $322 Million
7.09%
% of portfolio
0.04%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,842Shares Held
1.96BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$21.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.8 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$10.2 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.61 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$5.07 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $218B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...